InflaRx Begin Period Cash Flow from 2010 to 2024

IFRX Stock  USD 2.36  0.05  2.16%   
InflaRx NV Begin Period Cash Flow yearly trend continues to be fairly stable with very little volatility. Begin Period Cash Flow will likely drop to about 15.5 M in 2024. Begin Period Cash Flow is the amount of cash InflaRx NV has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities. View All Fundamentals
 
Begin Period Cash Flow  
First Reported
2016-09-30
Previous Quarter
25.1 M
Current Value
19.2 M
Quarterly Volatility
34.8 M
 
Covid
Check InflaRx NV financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among InflaRx NV's main balance sheet or income statement drivers, such as Interest Income of 3.2 M, Discontinued Operations of 0.0 or Depreciation And Amortization of 342.2 K, as well as many indicators such as Price To Sales Ratio of 788, Dividend Yield of 0.0 or PTB Ratio of 0.83. InflaRx financial statements analysis is a perfect complement when working with InflaRx NV Valuation or Volatility modules.
  
Check out the analysis of InflaRx NV Correlation against competitors.
For more information on how to buy InflaRx Stock please use our How to Invest in InflaRx NV guide.

Latest InflaRx NV's Begin Period Cash Flow Growth Pattern

Below is the plot of the Begin Period Cash Flow of InflaRx NV over the last few years. It is the amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities. InflaRx NV's Begin Period Cash Flow historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in InflaRx NV's overall financial position and show how it may be relating to other accounts over time.
Begin Period Cash Flow10 Years Trend
Slightly volatile
   Begin Period Cash Flow   
       Timeline  

InflaRx Begin Period Cash Flow Regression Statistics

Arithmetic Mean24,525,776
Geometric Mean14,671,749
Coefficient Of Variation125.81
Mean Deviation19,464,072
Median15,452,087
Standard Deviation30,856,390
Sample Variance952.1T
Range120M
R-Value0.31
Mean Square Error929T
R-Squared0.09
Significance0.27
Slope2,115,121
Total Sum of Squares13329.6T

InflaRx Begin Period Cash Flow History

202415.5 M
202316.3 M
202226.2 M
202126 M
202033.1 M
201955.4 M
2018123.3 M

About InflaRx NV Financial Statements

InflaRx NV investors use historical fundamental indicators, such as InflaRx NV's Begin Period Cash Flow, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in InflaRx NV. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Begin Period Cash Flow16.3 M15.5 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for InflaRx Stock Analysis

When running InflaRx NV's price analysis, check to measure InflaRx NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InflaRx NV is operating at the current time. Most of InflaRx NV's value examination focuses on studying past and present price action to predict the probability of InflaRx NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InflaRx NV's price. Additionally, you may evaluate how the addition of InflaRx NV to your portfolios can decrease your overall portfolio volatility.